Camurus AB

CAMX NPV
Create an alert
Sell614.00 SEK
Buy615.50 SEK
10.50 SEK (1.74%)
Last updated today at
Trade

Key metrics

Open603.50 SEK
Previous close604.00 SEK
Market capSEK 36.58bn
P/E ratio49.28
Volume101,690
Dividend yield0.00%
EMS-

Company information

Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and ...

  • LocationSweden
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencySEK
  • Shares in issue60.56m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Balance sheet 2025

Total assetsSEK 4.74bn
Total liabilitiesSEK 504.56m
Net debt-SEK 3.62bn

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Accounts to trade in

Explore the accounts you can trade this stock in.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.